Did you know?

MNKD's job is to make the product and to develop and start executing a plan for afrezza in the T2 market. Tyvaso DPI is never going to make MNKD rich. It will help pay some bills. Afrezza taking even 10% of the T2 market will make MNKD rich. The T1 market plan looks solid.Here it is in the transcript. Mike said, " There is an IP update from United Therapeutics in their recent quarterly earnings, where we heard the patent for ILD should be issued and give allowance through 2042." It's a little misleading because what the patent will not do is prevent LQDA from selling into the PH-ILD market.Message board for discussion of MNKD, MannKind Corporation. That post prandial control goes first has been known for a long time (decades) which is why you have the OGTT, Oral Glucose tolerance test, as part of the diagnosis for Type 2.MNKD | May 24, 2023. DANBURY, Conn., May 24, 2023 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced Burkhard Blank, MD, has joined the company as …At Fidelity, from my Summary page, I go to: Statements. then a tab. Proxy Materials. is available. In the resulting table I see a column "Proxy Type/Control Number" with the information. You might also try searching for "Proxy" or "Proxy Materials and Voting".Post by limo onMar 1, 2023 at 12:00pm. NOVO NORDISK – Eli Lilly news small for Novo's. New York Times says ‘’Eli Lilly said it would cut the price of insulin, capping the monthly out-of-pocket cost of the lifesaving drug at $35’’. WE say: US insulin business is less than 5% of revenue for NOVO (It’s all about GLP, and Obesity).Sentiment: Way Too Long. MNKD to Participate in Oppenheimer 33rd Annual Healthcare Co. Mar 22, 2023 at 6:07pm nemzter, sportsrancho, and 10 more like this. Reply Quote.Dec 10, 2014 at 2:39pm kj23 said: The CafePharma boards tend to be cesspools more often than not so I would take anything I read there with a grain of salt. I agree with you as another poster wasn't sure it was coming in 2015. kj23. Newbie. Posts: 2. Check out cafepharma Sanofi message board. Dec 10, 2014 at 3:18pm.If Mannkind had failed a few years back as some projected, there would be no story. If however, this goes on to great success as many now believe, the stories are going to make a hit movie; Al Mann being personally confronted by Shkreli, Shkreli gaslighting the FDA to issue the CRL causing a lengthy delay, the personal story lines of …Thank you Wyattdog! And thank you MannKind for paying your employees with stock that costs us next to nothing! ;-) mytakeonit. Postaholic. Posts: 5,805. Sentiment: Short Pretending to be Long. Form S-8 MANNKIND CORP. Aug 23, 2023 at 6:49pm alethea, prcgorman2, and 1 more like this.Post by buyitonsale onJun 28, 2022 at 10:28pm. MNKD current market cap is around $1 billion. At $8 per share, it will be valued around $2 billion. LQDA current market cap is around $300 million. At $15 per share, it will be valued around $900 million. Comparing share prices is not a way to establish valuation.Message board for discussion of MNKD, MannKind Corporation. Best I recall is the One Drop CEO was a strong proponent of Afrezza. Some here suggested the two should merge or partner and take on the industry while others countered that a CGM company would not be smart to limit their relationship to only one supplier which would effectively remove them from the big pie target audience.MannKind MNKD Message Board. All About MNKD. ADA 2020. MannKind. All About MNKD. MNKD Product Script Counts and Other Metrics. Articles. MNKD Resource Center. Off Topic. Other BioPharma Stocks. Other Stocks. Markets and Media. Trading and Investing Strategies. Really Off Topic. The Lighter Side. Documents and User Tips. Reply; ADA 2020. Share ...nobodysbusiness: Script numbers from proboards: "For week ending 6/23/17 TRx 334 (385 last week) TRx $ 268.27k TRx units in total prescriptions 64.44k NRx 1...Message board for discussion of MNKD, MannKind Corporation.

Yesterday's deal with UT has put a serious valuation to Mannkind's technosphere technology. We are talking about almost $100m (upfront & milestones) in cash that will be paid to MNKD for a drugMNKD volume is increasing on this mornings rebound Volume: 308,217 $5.26 0.20%-0.011 Today Aug 15, 10:12:27 AM UTC-4 · NASDAQ - 120 Heavy volume for MNKD at 1 hour of trade,As you look at Q2, Afrezza TRxs grew 16% versus last year, mainly driven by the Medicare access that was created under law in January of 2023. Tyvasso. to give clarity for our shareholders that for every 10,000 paying patients, we expect annual revenue demand kind between $250 million to $300 million.MannKind MNKD Message Board. All About MNKD. $4 limbo. MannKind. All About MNKD. MNKD Product Script Counts and Other Metrics. Articles. MNKD Resource Center. Off Topic. Other BioPharma Stocks. Other Stocks. Markets and Media. Trading and Investing Strategies. Really Off Topic. The Lighter Side. Documents and User Tips. Reply; $4 limbo. Share ...

Hello short bashing stealth readers (Zatol, Adam, Martin & friends). Posts: 2,723 Sentiment: Long. Naked Shorting Poll Feb 14, 2023 10:36:54 GMT -5 alethea, sr71, and 7 more like thisBig difference in finacials from 5 years ago thanks to the excellent work of the Mannkind team and a great partnership with UTHR. I agree clofazimine might yield a pleasant bit of news, but I do think the pleasantness would be less around what the FDA had to say about developing an inhalable form of the orphan drug and more about a partner like UTHR who will pay for development and marketing ...…

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Message board for discussion of MNKD, Man. Possible cause: They lie, we know they are lying, they know we know they are lying, and tomor.